Surface Oncology to Present Clinical Updates for SRF388 and SRF617

CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company …

  • You already voted!
  • Read More

Get Unlimited Free Access

Join 10,000 other readers who get their news from us